Gaviscon, mint 48 pcs.
€17.47 €14.56
Geviscon enters the stomach and interacts with its contents, forming a protective barrier (raft) that prevents the onset of heartburn.
The antacid drug. After ingestion, the drug quickly interacts with the acidic contents of the stomach. It forms alginate gel which has almost neutral pH value.
The gel forms a protective barrier on the surface of the stomach contents preventing the occurrence of gastroesophageal reflux for up to 4 hours. In the case of regurgitation, the gel is more likely to enter the esophagus, where it reduces mucosal irritation.
The reduction of esophageal mucosal irritation is felt 3-4 minutes after taking the drug.
Pharmacokinetics
The drug has no systemic bioavailability (not absorbed).
Indications
Composition
1 tablet
Sodium alginate 250 mg
Sodium bicarbonate 133.5 mg
calcium carbonate 80 mg
Associated substances:
Mannitol – 255 mg,
Macrogol 20,000 – 30 mg,
magnesium stearate – 4 mg,
aspartame – 3.75 mg,
copovidone – 28 mg,
potassium acesulfame – 3.75 mg,
mint flavoring – 12 mg.
How to take, the dosage
Interaction
Special Instructions
In a dose of 4 tablets, the sodium content is 246 mg, which should be considered when it is necessary to follow a diet with limited salt content (in congestive heart failure, with impaired renal function).
Each dose of 4 tablets contains 320 mg of calcium carbonate. Caution is necessary when treating patients with hypercalcemia, nephrocalcinosis and urolithiasis with formation of oxalate stones.
The drug contains aspartame, so it should not be used in patients with phenylketonuria. Because aspartame is a non-specific sweetener, patients with diabetes may use Gaviscon®.
The effect of the drug on driving and operating machinery
The drug does not affect the ability to drive vehicles and operate machinery as well as engage in other potentially dangerous activities requiring increased concentration and quick psychomotor reactions.
Contraindications
Side effects
Overdose
Symptoms: bloating.
Treatment: symptomatic therapy.
Weight | 0.100 kg |
---|---|
Shelf life | 2 years. |
Conditions of storage | The drug should be kept out of reach of children at a temperature not exceeding 30 ° C. |
Manufacturer | Reckitt Benckiser Healthcare International Ltd, United Kingdom |
Medication form | chewable tablets |
Brand | Reckitt Benckiser Healthcare International Ltd |
Other forms…
Related products
Buy Gaviscon, mint 48 pcs. with delivery to USA, UK, Europe and over 120 other countries.